Evidence map›Paper›PMID 38370737›Full record

ArticlebioRxiv : the preprint server for biology2024

Unfolded Von Willebrand Factor Binds Protein S and Reduces Anticoagulant Activity.

Martha M S Sim, Molly Y Mollica, Hammodah R Alfar, Melissa Hollifield, Dominic W Chung, Xiaoyun Fu, Siva Gandhapudi, Daniëlle M Coenen, Kanakanagavalli Shravani Prakhya, Dlovan F D Mahmood and 15 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 3 institutions in 1 country.

Martha M S SimDepartment of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
Molly Y MollicaBloodworks Northwest Research Institute, WA, USA.
Hammodah R AlfarDepartment of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
Melissa HollifieldDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
Dominic W ChungBloodworks Northwest Research Institute, WA, USA.
Xiaoyun FuBloodworks Northwest Research Institute, WA, USA.
Siva GandhapudiDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
Daniëlle M CoenenDepartment of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.ORCID 0000-0001-9036-9685
Kanakanagavalli Shravani PrakhyaDepartment of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
Dlovan F D MahmoodSaha Cardiovascular Research Center, University of Kentucky, KY, USA.
Meenakshi BanerjeeDepartment of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
Chi PengDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, KY, USA.
Xian LiSaha Cardiovascular Research Center, University of Kentucky, KY, USA.
Alice C ThorntonDivision of Infectious Disease, University of Kentucky, KY, USA.
James Z PorterfieldDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
Jamie L SturgillDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
Gail A SievertCenter for Clinical and Translational Science, University of Kentucky, KY, USA.
Marietta Barton-BaxterCenter for Clinical and Translational Science, University of Kentucky, KY, USA.
Ze ZhengDepartment of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Kenneth S CampbellCenter for Clinical and Translational Science, University of Kentucky, KY, USA.ORCID 0000-0001-5615-5958
Jerold G WoodwardDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
José A LópezBloodworks Northwest Research Institute, WA, USA.
Sidney W WhiteheartDepartment of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
Beth A GarvyDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
Jeremy P WoodDepartment of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.ORCID 0000-0001-5487-852X
University of Kentucky · USUniversity of Washington · USMedical College of Wisconsin · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
RESEARCH TRAINING IN HEMATOLOGYT32HL007093 · NHLBI · UNIVERSITY OF WASHINGTON · PI Janis L Abkowitz · 1985 to 2026
$13.9M
Platelet Exocytosis and Endocytosis in Thrombosis and ImmunityR35HL150818 · NHLBI · UNIVERSITY OF KENTUCKY · PI SIDNEY Waldo WHITEHEART · 2020 to 2026
$6.5M
Molecular and Translational Studies in Hematologic DisordersR35HL145262 · NHLBI · BLOODWORKS · PI LOPEZ, JOSE ARON · 2019 to 2024
$6.5M
MOLECULAR MECHANISMS OF PLATELET EXOCYTOSISR01HL056652 · NHLBI · UNIVERSITY OF KENTUCKY · PI WHITEHEART, SIDNEY WALDO · 1996 to 2019
$5.2M
NRSA Training CoreTL1TR001997 · NCATS · UNIVERSITY OF KENTUCKY · PI PENDERGAST, JULIE S, STOOPS, WILLIAM WALTON · 2016 to 2025
$4.2M
Platelet Endocytosis in Innate ImmunityR01HL138179 · NHLBI · UNIVERSITY OF KENTUCKY · PI WHITEHEART, SIDNEY WALDO · 2017 to 2019
$1.3M
Protein S Anticoagulant Activity: Biochemical Mechanisms and Structural StudiesR00HL129193 · NHLBI · UNIVERSITY OF KENTUCKY · PI WOOD, JEREMY P · 2018 to 2020
$736k
Protein S Anticoagulant Activity: Biochemical Mechanisms and Structural StudiesK99HL129193 · NHLBI · VERSITI WISCONSIN, INC. · PI WOOD, JEREMY P · 2015 to 2016
$192k
Targeting Platelet Endocytosis and Exocytosis to Control ThrombosisI01BX003877 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI WHITEHEART, SIDNEY WALDO · 2018 to 2022
–
BLRD VA I01 BX003877NCATS NIH HHS TL1 TR001997NCI NIH HHS P30 CA177558NHLBI NIH HHS K99 HL129193NHLBI NIH HHS R00 HL129193NHLBI NIH HHS R01 HL056652NHLBI NIH HHS R01 HL138179NHLBI NIH HHS R35 HL145262NHLBI NIH HHS R35 HL150818NHLBI NIH HHS T32 HL007093
6 · The paper itself

Abstract

Protein S (PS), the critical plasma cofactor for the anticoagulants tissue factor (TF) pathway inhibitor (TFPI) and activated protein C (APC), circulates in two functionally distinct pools: free (anticoagulant) or bound to complement component 4b-binding protein (C4BP) (anti-inflammatory). Acquired free PS deficiency is detected in several viral infections, but its cause is unclear. Here, we identified a shear-dependent interaction between PS and von Willebrand Factor (VWF) by mass spectrometry. Consistently, plasma PS and VWF comigrated in both native and agarose gel electrophoresis. The PS/VWF interaction was blocked by TFPI but not APC, suggesting an interaction with the C-terminal sex hormone binding globulin (SHBG) region of PS. Microfluidic systems, mimicking arterial laminar flow or disrupted turbulent flow, demonstrated that PS stably binds VWF as VWF unfolds under turbulent flow. PS/VWF complexes also localized to platelet thrombi under laminar arterial flow. In thrombin generation-based assays, shearing plasma decreased PS activity, an effect not seen in the absence of VWF. Finally, free PS deficiency in COVID-19 patients, measured using an antibody that binds near the C4BP binding site in SHBG, correlated with changes in VWF, but not C4BP, and with thrombin generation. Our data suggest that PS binds to a shear-exposed site on VWF, thus sequestering free PS and decreasing its anticoagulant activity, which would account for the increased thrombin generation potential. As many viral infections present with free PS deficiency, elevated circulating VWF, and increased vascular shear, we propose that the PS/VWF interaction reported here is a likely contributor to virus-associated thrombotic risk.

Indexed as

InfectionProtein CProtein S deficiencyThrombinvon Willebrand Factor

Identifiers

PMID38370737
PMCPMC10871343
OpenAlexW4391694530

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.